Skip to content

Alercell Appoints Dr. Paul A. Dreschnack to Advisory Board

Alercell has appointed Dr. Paul A. Dreschnack, a Harvard surgeon and four-time Nobel Peace Prize nominee, to its advisory board. Dr. Dreschnack will assist in the clinical translation of Alercell’s LENA Platform, which focuses on pre-symptomatic detection of blood cancers.

Microsurgeon and stemcell therapeutics pioneer joins Alercell to inform clinical translation of the LENA Platform for pre-symptomatic detection of blood cancers

BOZEMAN, MT, UNITED STATES, June 2, 2026 /⁨EINPresswire.com⁩/ — Alercell, Inc., a Montana- …